- Home
- NXT vs NBIX Comparison
NXT vs NBIX Comparison
Compare NXT & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXT | NBIX |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6B | 14.4B |
| IPO Year | 2023 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NXT | NBIX |
|---|---|---|
| Price | $90.36 | $154.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 19 |
| Target Price | $91.80 | ★ $174.84 |
| AVG Volume (30 Days) | ★ 2.1M | 924.1K |
| Earning Date | 01-27-2026 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.44 |
| EPS | 3.85 | ★ 4.19 |
| Revenue | ★ $3,373,226,000.00 | $2,682,700,000.00 |
| Revenue This Year | $17.63 | $23.76 |
| Revenue Next Year | $11.43 | $18.01 |
| P/E Ratio | ★ $23.20 | $37.13 |
| Revenue Growth | ★ 20.37 | 19.61 |
| 52 Week Low | $33.29 | $84.23 |
| 52 Week High | $112.74 | $160.18 |
Technical Indicators
Market Signals| Indicator | NXT | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 60.53 |
| Support Level | $86.58 | $151.59 |
| Resistance Level | $91.45 | $156.70 |
| Average True Range (ATR) | 4.34 | 4.24 |
| MACD | -0.02 | 0.60 |
| Stochastic Oscillator | 77.87 | 70.35 |
Price Performance
Historical ComparisonAbout NXT Nextracker Inc.
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.